for people ages 60-85 (full criteria)
at San Francisco, California and other locations
study started
estimated completion



The purpose of this study is to evaluate the safety and efficacy of a study drug that targets an abnormal protein in the brain found in people with Alzheimer's Disease (AD).

Official Title

Assessment of Safety, Tolerability, and Efficacy of LY3303560 in Early Symptomatic Alzheimer's Disease


Alzheimer Disease (AD) Memory problems Cognitive impairment PERISCOPE-ALZ Dementia Tauopathy Neurofibrillary tangles Alzheimer Disease LY3303560 Dose 1 LY3303560 Dose 2


You can join if…

Open to people ages 60-85

  • Participants must have gradual and progressive change in memory function for >6 months.
  • Participants must have a family member or close friend who is with you at least 10 hours per week and can attend study appointments.

You CAN'T join if...

  • Participants must not have significant neurological disease affecting the nervous system, other than AD, that affects cognition or may affect completion of the study.
  • Participants must not have serious or unstable illness that could interfere with the analysis of the study or has a life expectancy <24 months.
  • Participants must not have history of cancer within the last 5 years with the exception of certain types of skin, cervical, prostate, and other cancers that are not likely to recur or spread.
  • Participants must not have serious risk for suicide.
  • Participants must not have history of drug or alcohol use disorder within the last 2 years.
  • Participants must not have multiple severe drug allergies
  • Participants must not have HIV, Hepatitis B or Hepatitis C
  • Participants must not be receiving gamma globulin (IgG) or intravenous immunoglobulin (IVIG) therapy


  • Univ of California San Francisco
    San Francisco California 94158 United States
  • National Research Institute
    Panorama City California 91402 United States


in progress, not accepting new patients
Start Date
Completion Date
Eli Lilly and Company
Phase 2
Study Type
Last Updated